家庭用ヘルスケアの世界市場分析:コンポーネント別{機器(治療、診断、移動支援)}、サービス別(リハビリ、家族による在宅ケア、呼吸療法サービス、輸液療法サービス、テレメトリー)、セグメント予測、2014-2025...市場調査レポートについてご紹介

【英文タイトル】Home Healthcare Market Analysis By Component {Equipment (Therapeutic, Diagnostic, Mobility Assist)}, Services (Rehabilitation, Unskilled Home Care, Respiratory Therapy Services, Infusion Therapy Services, Telemetry), And Segment Forecasts, 2014-2025

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
Chapter 3. Home Healthcare Market Variables, Trends & Scope
3.1. Market Segmentation & Scope
3.2. Market Driver Analysis
3.3. Penetration & Growth Prospect Mapping
3.4. SWOT Analysis, By Factor
3.4.1. Political
3.4.2. Economic
3.4.3. Technological
3.5. Industry Analysis – Porter’s
Chapter 4. Home Healthcare Component Estimates & Trend Analysis
4.1. Home Healthcare Movement Analysis & Market Share, 2015 & 2025
4.2. Market Size Estimates & Forecasts and Trend Analyses, 2014 to 2025 (USD Billion) for the Following Components:
4.2.1. Equipment
4.2.1.1. Therapeutic
4.2.1.1.1. Home Respiratory Equipment
4.2.1.1.2. Insulin Delivery Device
4.2.1.1.3. Home IV Pumps
4.2.1.1.4. Home Dialysis Equipment
4.2.1.1.5. Other Therapeutic Equipment
4.2.1.2. Diagnostics
4.2.1.2.1. Diabetic Care Unit
4.2.1.2.2. BP Monitors
4.2.1.2.3. Multi Parameter Diagnostic Monitors
4.2.1.2.4. Home Pregnancy and Fertility Kits
4.2.1.2.5. Other Self-Monitoring Equipment
4.2.1.2.6. Apnea and Sleep Monitors
4.2.1.2.7. Holter Monitors
4.2.1.2.8. Heart Rate Maters
4.2.1.2.9. Other
4.2.1.3. Mobility Assists
4.2.1.3.1. Rehabilitation Services
4.2.1.3.2. Unskilled Home Care
4.2.1.3.3. Respiratory Therapy Services
4.2.1.3.4. Infusion Therapy Services
4.2.1.3.5. Telemetry
4.2.2. Services
4.2.2.1.1. Rehabilitation Services
4.2.2.1.2. Unskilled Home Care
4.2.2.1.3. Respiratory Therapy Services
4.2.2.1.4. Infusion Therapy Services
4.2.2.1.5. Telemetry
Chapter 5. Home Healthcare Regional Estimates & Trend Analysis
5.1. Regional Movement Analysis & Market Share, 2015 & 2025
5.2. North America
5.2.1. U.S.
5.2.1.1. U.S. revenue estimates and forecasts by, component (USD Billion) 2014 – 2025
5.2.2. Canada
5.2.2.1. Canada revenue estimates and forecasts by, component (USD Billion) 2014 – 2025
5.3. Europe
5.3.1. UK
5.3.1.1. UK revenue estimates and forecasts by, component (USD Billion) 2014 – 2025
5.3.2. Germany
5.3.2.1. Germany revenue estimates and forecasts by, component (USD Billion) 2014 – 2025
5.4. Asia Pacific
5.4.1. Japan
5.4.1.1. Japan revenue estimates and forecasts by, component (USD Billion) 2014 – 2025
5.4.2. China
5.4.2.1. China revenue estimates and forecasts by, component (USD Billion) 2014 – 2025
5.5. Latin America
5.5.1. Brazil
5.5.1.1. Brazil revenue estimates and forecasts by, component (USD Billion) 2014 – 2025
5.5.2. Mexico
5.5.2.1. Mexico revenue estimates and forecasts by, component (USD Billion) 2014 – 2025
5.6. MEA
5.6.1. South Africa
5.6.1.1. South Africa revenue estimates and forecasts by, component (USD Billion) 2014 – 2025
Chapter 6. Competitive Landscape
6.1. Strategy Framework
6.2. Company Profiles
6.2.1. Almost Family Inc.
6.2.1.1. Company Overview
6.2.1.2. Financial Performance
6.2.1.3. Product Benchmarking
6.2.1.4. Strategic Initiatives
6.2.2. B. Braun Melsungen AG
6.2.2.1. Company Overview
6.2.2.2. Financial Performance
6.2.2.3. Product Benchmarking
6.2.2.4. Strategic Initiatives
6.2.3. Abbott Laboratories
6.2.3.1. Company Overview
6.2.3.2. Financial Performance
6.2.3.3. Product Benchmarking
6.2.3.4. Strategic Initiatives
6.2.4. Sunrise Medical Inc.
6.2.4.1. Company Overview
6.2.4.2. Financial Performance
6.2.4.3. Product Benchmarking
6.2.4.4. Strategic Initiatives
6.2.5. 3M Healthcare
6.2.5.1. Company Overview
6.2.5.2. Financial Performance
6.2.5.3. Product Benchmarking
6.2.5.4. Strategic Initiatives
6.2.6. Baxter International Inc.
6.2.6.1. Company Overview
6.2.6.2. Financial Performance
6.2.6.3. Product Benchmarking
6.2.6.4. Strategic Initiatives
6.2.7. Medtronic
6.2.7.1. Company Overview
6.2.7.2. Financial Performance
6.2.7.3. Product Benchmarking
6.2.7.4. Strategic Initiatives
6.2.8. Cardinal Health Inc.
6.2.8.1. Company Overview
6.2.8.2. Financial Performance
6.2.8.3. Product Benchmarking
6.2.8.4. Strategic Initiatives
6.2.9. Roche Diagnostics Corp.
6.2.9.1. Company Overview
6.2.9.2. Financial Performance
6.2.9.3. Product Benchmarking
6.2.9.4. Strategic Initiatives
6.2.10. Roche Diagnostics Corp.
6.2.10.1. Company Overview
6.2.10.2. Financial Performance
6.2.10.3. Product Benchmarking
6.2.10.4. Strategic Initiatives
6.2.11. Roche Diagnostics Corp.
6.2.11.1. Company Overview
6.2.11.2. Financial Performance
6.2.11.3. Product Benchmarking
6.2.11.4. Strategic Initiatives
6.2.12. Air Liquide
6.2.12.1. Company Overview
6.2.12.2. Financial Performance
6.2.12.3. Product Benchmarking
6.2.12.4. Strategic Initiatives
6.2.13. Arcadia Resources, Inc.
6.2.13.1. Company Overview
6.2.13.2. Financial Performance
6.2.13.3. Product Benchmarking
6.2.13.4. Strategic Initiatives
6.2.14. Bayer Healthcare AG
6.2.14.1. Company Overview
6.2.14.2. Financial Performance
6.2.14.3. Product Benchmarking
6.2.14.4. Strategic Initiatives
6.2.15. Amedisys, Inc.
6.2.15.1. Company Overview
6.2.15.2. Financial Performance
6.2.15.3. Product Benchmarking
6.2.15.4. Strategic Initiatives
6.2.16. Nxstage Medical, Inc
6.2.16.1. Company Overview
6.2.16.2. Financial Performance
6.2.16.3. Product Benchmarking
6.2.16.4. Strategic Initiatives
6.2.17. Arkray Inc.
6.2.17.1. Company Overview
6.2.17.2. Financial Performance
6.2.17.3. Product Benchmarking
6.2.17.4. Strategic Initiatives
6.2.18. Apria Healthcare Group
6.2.18.1. Company Overview
6.2.18.2. Financial Performance
6.2.18.3. Product Benchmarking
6.2.18.4. Strategic Initiatives
6.2.19. Odyssey Healthcare Inc.
6.2.19.1. Company Overview
6.2.19.2. Financial Performance
6.2.19.3. Product Benchmarking
6.2.19.4. Strategic Initiatives
6.2.20. Becton, Dickinson and Company
6.2.20.1. Company Overview
6.2.20.2. Financial Performance
6.2.20.3. Product Benchmarking
6.2.20.4. Strategic Initiatives
6.2.21. Critical Homecare
6.2.21.1. Company Overview
6.2.21.2. Financial Performance
6.2.21.3. Product Benchmarking
6.2.21.4. Strategic Initiatives
6.2.22. National Healthcare Corp.
6.2.22.1. Company Overview
6.2.22.2. Financial Performance
6.2.22.3. Product Benchmarking
6.2.22.4. Strategic Initiatives
6.2.23. Omron Healthcare, Inc.
6.2.23.1. Company Overview
6.2.23.2. Financial Performance
6.2.23.3. Product Benchmarking
6.2.23.4. Strategic Initiatives
6.2.24. Drive Medical Design & Manufacturing
6.2.24.1. Company Overview
6.2.24.2. Financial Performance
6.2.24.3. Product Benchmarking
6.2.24.4. Strategic Initiatives
6.2.25. Chubb Community Care
6.2.25.1. Company Overview
6.2.25.2. Financial Performance
6.2.25.3. Product Benchmarking
6.2.25.4. Strategic Initiatives
6.2.26. Gambro AB
6.2.26.1. Company Overview
6.2.26.2. Financial Performance
6.2.26.3. Product Benchmarking
6.2.26.4. Strategic Initiatives
6.2.27. GE Healthcare
6.2.27.1. Company Overview
6.2.27.2. Financial Performance
6.2.27.3. Product Benchmarking
6.2.27.4. Strategic Initiatives
6.2.28. Medline Industries Inc.
6.2.28.1. Company Overview
6.2.28.2. Financial Performance
6.2.28.3. Product Benchmarking
6.2.28.4. Strategic Initiatives
6.2.29. Philips Healthcare
6.2.29.1. Company Overview
6.2.29.2. Financial Performance
6.2.29.3. Product Benchmarking
6.2.29.4. Strategic Initiatives
6.2.30. Medco Health Solutions Inc.
6.2.30.1. Company Overview
6.2.30.2. Financial Performance
6.2.30.3. Product Benchmarking
6.2.30.4. Strategic Initiatives
6.2.31. Graham-Field Health Products Inc.
6.2.31.1. Company Overview
6.2.31.2. Financial Performance
6.2.31.3. Product Benchmarking
6.2.31.4. Strategic Initiatives
6.2.32. Hill-Rom Holdings Inc.
6.2.32.1. Company Overview
6.2.32.2. Financial Performance
6.2.32.3. Product Benchmarking
6.2.32.4. Strategic Initiatives
6.2.33. Gentiva Health Services Inc
6.2.33.1. Company Overview
6.2.33.2. Financial Performance
6.2.33.3. Product Benchmarking
6.2.33.4. Strategic Initiatives
6.2.34. Johnson & Johnson
6.2.34.1. Company Overview
6.2.34.2. Financial Performance
6.2.34.3. Product Benchmarking
6.2.34.4. Strategic Initiatives
6.2.35. Linde Healthcare
6.2.35.1. Company Overview
6.2.35.2. Financial Performance
6.2.35.3. Product Benchmarking
6.2.35.4. Strategic Initiatives
6.2.36. Lincare Holdings, Inc.
6.2.36.1. Company Overview
6.2.36.2. Financial Performance
6.2.36.3. Product Benchmarking
6.2.36.4. Strategic Initiatives
6.2.37. Kinetic Concepts
6.2.37.1. Company Overview
6.2.37.2. Financial Performance
6.2.37.3. Product Benchmarking
6.2.37.4. Strategic Initiatives
6.2.38. Carefusion
6.2.38.1. Company Overview
6.2.38.2. Financial Performance
6.2.38.3. Product Benchmarking
6.2.38.4. Strategic Initiatives
6.2.39. Vygon
6.2.39.1. Company Overview
6.2.39.2. Financial Performance
6.2.39.3. Product Benchmarking
6.2.39.4. Strategic Initiatives
6.2.40. Teleflex
6.2.40.1. Company Overview
6.2.40.2. Financial Performance
6.2.40.3. Product Benchmarking
6.2.40.4. Strategic Initiatives
6.2.41. Moog Inc.
6.2.41.1. Company Overview
6.2.41.2. Financial Performance
6.2.41.3. Product Benchmarking
6.2.41.4. Strategic Initiatives
6.2.42. Intersurgical
6.2.42.1. Company Overview
6.2.42.2. Financial Performance
6.2.42.3. Product Benchmarking
6.2.42.4. Strategic Initiatives
6.2.43. Fresenius Kabi
6.2.43.1. Company Overview
6.2.43.2. Financial Performance
6.2.43.3. Product Benchmarking
6.2.43.4. Strategic Initiatives


【レポート販売概要】

■ タイトル:家庭用ヘルスケアの世界市場分析:コンポーネント別{機器(治療、診断、移動支援)}、サービス別(リハビリ、家族による在宅ケア、呼吸療法サービス、輸液療法サービス、テレメトリー)、セグメント予測、2014-2025
■ 英文:Home Healthcare Market Analysis By Component {Equipment (Therapeutic, Diagnostic, Mobility Assist)}, Services (Rehabilitation, Unskilled Home Care, Respiratory Therapy Services, Infusion Therapy Services, Telemetry), And Segment Forecasts, 2014-2025
■ 発行日:2017年1月4日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707402
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。